DE2505066A1 - Parainfluenza-virus-vakzine zur bekaempfung der tracheobronchitis von hunden - Google Patents
Parainfluenza-virus-vakzine zur bekaempfung der tracheobronchitis von hundenInfo
- Publication number
- DE2505066A1 DE2505066A1 DE19752505066 DE2505066A DE2505066A1 DE 2505066 A1 DE2505066 A1 DE 2505066A1 DE 19752505066 DE19752505066 DE 19752505066 DE 2505066 A DE2505066 A DE 2505066A DE 2505066 A1 DE2505066 A1 DE 2505066A1
- Authority
- DE
- Germany
- Prior art keywords
- virus
- gelatin
- vaccine
- dogs
- freeze
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000700605 Viruses Species 0.000 title claims description 87
- 206010044314 Tracheobronchitis Diseases 0.000 title claims description 11
- 208000002606 Paramyxoviridae Infections Diseases 0.000 title description 20
- 229960005486 vaccine Drugs 0.000 claims description 80
- 229920000159 gelatin Polymers 0.000 claims description 28
- 235000019322 gelatine Nutrition 0.000 claims description 28
- 241001465754 Metazoa Species 0.000 claims description 26
- 238000004113 cell culture Methods 0.000 claims description 24
- 108010010803 Gelatin Proteins 0.000 claims description 23
- 239000008273 gelatin Substances 0.000 claims description 23
- 235000011852 gelatine desserts Nutrition 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 21
- 241000282465 Canis Species 0.000 claims description 19
- 208000015181 infectious disease Diseases 0.000 claims description 17
- 239000000047 product Substances 0.000 claims description 12
- 210000004027 cell Anatomy 0.000 claims description 11
- 239000006228 supernatant Substances 0.000 claims description 11
- 238000002955 isolation Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 210000003292 kidney cell Anatomy 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 6
- 230000003834 intracellular effect Effects 0.000 claims description 6
- 239000006285 cell suspension Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 238000005119 centrifugation Methods 0.000 claims description 4
- 230000002458 infectious effect Effects 0.000 claims description 3
- 239000001828 Gelatine Substances 0.000 claims 5
- 238000011084 recovery Methods 0.000 claims 2
- 239000012535 impurity Substances 0.000 claims 1
- 230000002779 inactivation Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 230000006641 stabilisation Effects 0.000 claims 1
- 238000011105 stabilization Methods 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 241000282472 Canis lupus familiaris Species 0.000 description 131
- 238000002255 vaccination Methods 0.000 description 36
- 201000010099 disease Diseases 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 230000003442 weekly effect Effects 0.000 description 12
- 208000023504 respiratory system disease Diseases 0.000 description 11
- 210000002966 serum Anatomy 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 230000000241 respiratory effect Effects 0.000 description 9
- 238000007918 intramuscular administration Methods 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000007794 irritation Effects 0.000 description 6
- 230000003472 neutralizing effect Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000007423 decrease Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 241001353878 Canine parainfluenza virus Species 0.000 description 4
- 208000000655 Distemper Diseases 0.000 description 4
- 230000005875 antibody response Effects 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 208000010370 Adenoviridae Infections Diseases 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical group N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 208000014058 canine distemper Diseases 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 238000009021 pre-vaccination Methods 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 206010060931 Adenovirus infection Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101710178035 Chorismate synthase 2 Proteins 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 101710152694 Cysteine synthase 2 Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010024238 Leptospirosis Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 1
- 208000011589 adenoviridae infectious disease Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000010871 livestock manure Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004237 neck muscle Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 239000005723 virus inoculator Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44001574A | 1974-02-06 | 1974-02-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2505066A1 true DE2505066A1 (de) | 1975-08-07 |
Family
ID=23747082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19752505066 Withdrawn DE2505066A1 (de) | 1974-02-06 | 1975-02-06 | Parainfluenza-virus-vakzine zur bekaempfung der tracheobronchitis von hunden |
Country Status (10)
-
1975
- 1975-01-30 GB GB4031/75A patent/GB1495026A/en not_active Expired
- 1975-02-04 FR FR7503387A patent/FR2259617B1/fr not_active Expired
- 1975-02-04 AU AU77868/75A patent/AU497239B2/en not_active Expired
- 1975-02-05 CA CA219,440A patent/CA1039652A/en not_active Expired
- 1975-02-05 NO NO750364A patent/NO750364L/no unknown
- 1975-02-05 NL NL7501358A patent/NL7501358A/xx not_active Application Discontinuation
- 1975-02-05 SE SE7501244A patent/SE7501244L/ unknown
- 1975-02-06 DE DE19752505066 patent/DE2505066A1/de not_active Withdrawn
- 1975-02-06 IT IT67301/75A patent/IT1030101B/it active
- 1975-02-06 JP JP50015862A patent/JPS50140625A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU497239B2 (en) | 1978-12-07 |
| SE7501244L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-08-07 |
| FR2259617A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-08-29 |
| GB1495026A (en) | 1977-12-14 |
| NL7501358A (nl) | 1975-08-08 |
| CA1039652A (en) | 1978-10-03 |
| NO750364L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-09-01 |
| IT1030101B (it) | 1979-03-30 |
| JPS50140625A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-11-11 |
| FR2259617B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1978-08-04 |
| AU7786875A (en) | 1976-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4645665A (en) | Live infectious bronchitis vaccine for poultry | |
| DE2542792A1 (de) | Verfahren zur erhoehung der antikoerpermenge in der milch von milchabsondernden rindern | |
| WO2000047222A2 (de) | Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation | |
| DE2708668A1 (de) | Nd-impfstoff und verfahren zu seiner herstellung | |
| DE2817891A1 (de) | Nd-impfstoff und verfahren zu seiner herstellung | |
| CH622702A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| US4505892A (en) | Infectious bronchitis vaccine for poultry | |
| US4357320A (en) | Infectious bronchitis vaccine for poultry | |
| DE2423129A1 (de) | Verfahren zur herstellung temperaturempfindlicher, nicht pathogener mutantenstaemme von rinder-adeno-virusstaemmen und diese virusstaemme enthaltende lebendvakzine | |
| DE2362067C2 (de) | Temperaturempfindliche, nicht-pathogene, infektiöse Rinder-Rhinotracheitis-Virusstämme, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Lebendimpfstoffen | |
| DE2616407A1 (de) | Tollwut-vaccine und verfahren zu ihrer herstellung | |
| DE2120929A1 (de) | Impfstoff für Geflügel gegen die Mareksche Hühnerlähme und Verfahren zu seiner Herstellung | |
| DE2323847C3 (de) | Lebendimpfstoff zur Immunisierung von Rindern gegen die Parainfluenza-3-Virus-Infektion | |
| DE2445819A1 (de) | Verfahren zur herstellung stabiler, gegen seruminhibitoren resistenter h tief 3 n tief 2 -influenzavirusstaemme und diese virusstaemme enthaltende vakzinen | |
| DE69615772T2 (de) | Milder Newcastle-Krankheitsimpfstoff | |
| DE3034238A1 (de) | Impfstoff zur bekaempfung der newcastle-krankheit und verfahren zur herstellung derselben | |
| DE1198489B (de) | Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie | |
| US4500638A (en) | Infectious bronchitis virus strain | |
| DE2415353A1 (de) | Verfahren zur herstellung von temperaturempfindlichen, nicht pathogenen mutanten von herpes simplex typ 2-viren und ihre verwendung zur herstellung von vaccinen | |
| DE2456636A1 (de) | Influenza-vakzine und verfahren zu ihrer herstellung | |
| DE2360118A1 (de) | Vakzinen gegen ferkel-colibacillose und verfahren zu ihrer herstellung | |
| DE69231724T2 (de) | Fischimpfstoff gegen infektion mit aeromonas salmonicida | |
| DE2505066A1 (de) | Parainfluenza-virus-vakzine zur bekaempfung der tracheobronchitis von hunden | |
| DE69014974T2 (de) | Impfstoff gegen Hundecoronavirus. | |
| DE2057544C3 (de) | Impfstoff gegen ein neonatales Kälberdiarrhoevirus, Verfahren zu seiner Herstellung und seine Verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8141 | Disposal/no request for examination |